These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36994643)

  • 41. Iodized Oil Transarterial Chemoembolization and Radiofrequency Ablation for Small Periportal Hepatocellular Carcinoma: Comparison with Nonperiportal Hepatocellular Carcinoma.
    Lee SY; Hyun D; Cho SK; Shin SW; Jung SH; Chi SA
    Cardiovasc Intervent Radiol; 2018 Jan; 41(1):120-129. PubMed ID: 28924943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term outcome of percutaneous radiofrequency ablation for periportal hepatocellular carcinoma: tumor recurrence or progression, survival and clinical significance.
    Cao S; Lyu T; Fan Z; Guan H; Song L; Tong X; Wang J; Zou Y
    Cancer Imaging; 2022 Jan; 22(1):2. PubMed ID: 34983650
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CT-monitored minimal ablative margin control in single-session microwave ablation of liver tumors: an effective strategy for local tumor control.
    Joo I; Morrow KW; Raman SS; McWilliams JP; Sayre JW; Lu DS
    Eur Radiol; 2022 Sep; 32(9):6327-6335. PubMed ID: 35389047
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
    Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
    J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases.
    Laimer G; Jaschke N; Schullian P; Putzer D; Eberle G; Solbiati M; Solbiati L; Goldberg SN; Bale R
    Eur Radiol; 2021 Sep; 31(9):6489-6499. PubMed ID: 33447860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nomogram including chemotherapy response for prediction of intrahepatic progression-free survival in patients with colorectal liver metastasis through chemotherapy followed by radiofrequency ablation.
    Wu H; Liu GJ; Zhang ZY; Wu W; Meng YF; Wang S; Yang W; Yan K
    Int J Hyperthermia; 2021; 38(1):633-639. PubMed ID: 33882789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors.
    Yin XY; Xie XY; Lu MD; Xu HX; Xu ZF; Kuang M; Liu GJ; Liang JY; Lau WY
    Cancer; 2009 May; 115(9):1914-23. PubMed ID: 19241423
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microwave ablation for the treatment of hepatocellular carcinoma that met up-to-seven criteria: feasibility, local efficacy and long-term outcomes.
    Xu Y; Shen Q; Liu P; Xu Z; Wu P; Lu Z; Chen Y; Huang B; Qian G
    Eur Radiol; 2017 Sep; 27(9):3877-3887. PubMed ID: 28188425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radiofrequency versus microwave ablation for intraoperative treatment of colorectal liver metastases.
    Krul MF; Gerritsen SL; Vissers FL; Klompenhouwer EG; Ruers TJ; Kuhlmann KF; Kok NF
    Eur J Surg Oncol; 2022 Apr; 48(4):834-840. PubMed ID: 34686404
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term outcome of percutaneous radiofrequency ablation in recurrent hepatocellular carcinoma after liver transplantation.
    Yang W; Wu H; Zhang ZY; Lee JC; Wang S; Wang YJ; Wu W; Chen MH; Yan K
    Int J Hyperthermia; 2018 Feb; 34(1):68-76. PubMed ID: 28540818
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a propensity score analysis.
    Suwa K; Seki T; Aoi K; Yamashina M; Murata M; Yamashiki N; Nishio A; Shimatani M; Naganuma M
    Abdom Radiol (NY); 2021 Aug; 46(8):3790-3797. PubMed ID: 33675382
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination of radiofrequency ablation and transcatheter arterial chemoembolization to treat hepatocellular carcinoma: measurement of distance from needle tip to nodule for assessment of local tumor progression.
    Haochen W; Jian W; Li S; Tianshi L; Xiaoqiang T; Yinghua Z
    J Int Med Res; 2019 Jun; 47(6):2516-2523. PubMed ID: 31020891
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes.
    Hyun D; Cho SK; Shin SW; Park KB; Lee SY; Park HS; Do YS
    Acta Radiol; 2018 Jul; 59(7):773-781. PubMed ID: 29034691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single-centre retrospective review of risk factors for local tumour progression and complications in radiofrequency ablation of 555 hepatic lesions.
    Chua JME; Lam YMP; Tan BS; Tay KH; Gogna A; Irani FG; Lo HGR; Too CW
    Singapore Med J; 2019 Apr; 60(4):188-192. PubMed ID: 31069400
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical Outcomes and Predictors in Patients With Unresectable Colorectal Cancer Liver Metastases Following Salvage Percutaneous Radiofrequency Ablation: A Single Center Preliminary Experience.
    Wang Y; Zhang GY; Xu LC; He XH; Huang HZ; Li GD; Wang YH; Wang GZ; Li WT
    Technol Cancer Res Treat; 2020; 19():1533033820963662. PubMed ID: 33034276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Percutaneous radiofrequency ablation of adrenal metastases from hepatocellular carcinoma: a single-center experience.
    Huang J; Xie X; Lin J; Wang W; Zhang X; Liu M; Li X; Huang G; Liu B; Xie X
    Cancer Imaging; 2019 Jun; 19(1):44. PubMed ID: 31242934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The local efficacy and influencing factors of ultrasound-guided percutaneous microwave ablation in colorectal liver metastases: a review of a 4-year experience at a single center.
    Qin S; Liu GJ; Huang M; Huang J; Luo Y; Wen Y; Wang Y; Chen L
    Int J Hyperthermia; 2019; 36(1):36-43. PubMed ID: 30489175
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term Results.
    Seror O; N'Kontchou G; Nault JC; Rabahi Y; Nahon P; Ganne-Carrié N; Grando V; Zentar N; Beaugrand M; Trinchet JC; Diallo A; Sellier N
    Radiology; 2016 Aug; 280(2):611-21. PubMed ID: 27010381
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.
    Ng KK; Poon RT; Lo CM; Yuen J; Tso WK; Fan ST
    J Gastrointest Surg; 2008 Jan; 12(1):183-91. PubMed ID: 17874276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.